Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (221)
- COVID-19 (127)
- Medicines safety (111)
- Prescription medicines (88)
- COVID-19 vaccines (79)
- Regulatory compliance (76)
- Medicines (72)
- Legislation (63)
- Listed medicines (35)
- Medical devices (34)
- Medical devices safety (34)
- Therapeutic goods regulation (33)
- Non-prescription medicines (31)
- Safety (23)
- Scheduling (national classification system) (23)
- Unapproved therapeutic goods (23)
- Complementary medicines (22)
- Manufacturing (22)
- Assessed listed medicines (21)
- Labelling and packaging (16)
- Medicinal cannabis hub (13)
- Nicotine vaping products hub (11)
- Over the counter medicine (11)
- Shortages (11)
- Australian Register of Therapeutic Goods (ARTG) (9)
- Import and export (9)
- Sunscreens (8)
- In Vitro Diagnostic medical devices (IVDs) (7)
- Alert/Advisory (5)
- Compliance and enforcement hub (4)
- Advisory bodies and committees (3)
- Fees and payments (3)
- Other therapeutic goods (3)
- Biologicals (2)
- Cosmetics (2)
- Weight loss products (2)
- Biological medicines (1)
- Blood and blood components (1)
- Blood safety (1)
- Clinical trials (1)
- Prescription opioids hub (1)
- Travelling with health products (1)
- Unique Device Identification (UDI) hub (1)
Results for
"[search-keyword]"
Search
948 result(s) found, displaying 101 to 125
- Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Pfizer) (Tozinameran and Famtozinameran) Labelling Exemption 2023NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
- COVID-19 vaccine safety report - 09-02-23COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
- Avoid prescribing pregabalin in pregnancy if possibleSafety updatesMedicines Safety Update - Information for health professionals
- Direction about advertisements: Melbourne-based individualNoticesThe TGA has issued a direction notice to a Melbourne-based individual to cease advertising of all nicotine vaping products.
- Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatristsMedia releasesFrom 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions.
- TGA makes interim decision to reduce maximum paracetamol pack sizesMedia releasesThe TGA has today published an interim decision to reduce the maximum pack sizes for various paracetamol products.
- Caveman Nutrition Pty Ltd, The Cave Nutrition Store Pty Ltd and their director fined $208,000 for alleged unlawful advertising of sports supplements containing dangerous substancesMedia releasesThe TGA has issued infringement notices to Caveman Nutrition Pty Ltd, The Cave Nutrition Store Pty Ltd and to the director of these companies for the alleged unlawful advertising of sports supplements and therapeutic goods not included in the ARTG.
- JSHealth Vitamins Pty Ltd fined $13,320 for alleged unlawful supply of a complementary medicineMedia releasesThe TGA has issued an infringement notice totalling $13,320 to Sydney company JSHealth Vitamins Pty Ltd for supplying a complementary medicine that allegedly did not conform with legal requirements.
- Changes applying to evaluation of new substances for listed medicinesNewsNew guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.
- TGA confirms the performance of Australian approved Rapid Antigen Tests with COVID-19 VariantsMedia releasesThe TGA has confirmed the performance of COVID-19 rapid antigen tests available on the Australian market with COVID-19 variants.
- Therapeutic Goods (Permissible Ingredients - Application for Variation) Approval 2023NoticesThis instrument is made under subsection 26BD(3) of the Therapeutic Goods Act 1989.
- Mode Medical Pty Ltd and executive officer fined almost $160,000 for alleged unlawful advertising of intravenous infusion productsMedia releasesThe TGA has issued infringement notices to Mode Medical Pty Ltd for the alleged unlawful advertising to Australian consumers on a company website and social media.
- Product Information safety updates - January 2023Safety updatesMedicines Safety Update - Information for health professionals
- COVID-19 treatment: Gilead Sciences Pty Ltd, remdesivir (VEKLURY)NewsOn 10 July 2020 the Therapeutic Goods Administration (TGA) granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19
- COVID-19 treatment: GlaxoSmithKline Australia Pty Ltd, sotrovimab (XEVUDY)NewsOn 20 August 2021 the TGA granted provisional approval to GlaxoSmithKline Australia Pty Ltd in relation to sotrovimab (XEVUDY).
- COVID-19 vaccine safety report - 27-01-2023COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
- TGA grants provisional approval to Pfizer’s COVID-19 bivalent (COMIRNATY Original/Omicron BA.4-5 COVID-19 vaccine) booster dose vaccineMedia releasesThis is the first vaccine provisionally approved by the TGA that is designed to specifically target the Omicron variants BA.4/BA.5 and follows provisional approval of the Pfizer BA.1 Omicron/original bivalent vaccine.
- TGA commences evaluation of Moderna COVID-19 vaccine (SPIKEVAX) for potential transition to full registrationMedia releasesThe TGA has commenced evaluation of an application from Moderna Australia Pty Ltd to transition its COVID-19 vaccine, SPIKEVAX, to full registration for the immunisation of individuals 6 years and over, and as a booster dose for individuals aged 12 years and older.
- COVID-19 vaccine safety report – 12-01-2023COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
- Antibiotics shortage in AustraliaNewsCurrent antibiotics shortages in Australia include amoxicillin, amoxicillin/clavulanic acid, cefalexin, metronidazole and trimethoprim.
- COVID-19 vaccine safety report - 22-12-2022COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
- Access Generic Medicines work-sharing initiative updateNewsThe Generic Medicines Work-Sharing Initiative has updated its Operational Procedures document and Expression Of Interest form.
- Product Information safety updates - December 2022Safety updatesMedicines Safety Update - Information for health professionals
- TGA operations over the holiday period 2022-23NewsThe TGA will have limited operations from Friday 23 December 2022 until Tuesday 3 January 2023
- Travellers with injectable medicines containing ingredients derived from animal or human origin no longer require TGA approval to enter AustraliaMedia releasesTravellers will be able to bring up to 3-months supply of their medicine.